Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine
Jake S. O’Donnell(The University of Queensland), Keith J. Chappell(The University of Queensland)
Cited by 17
Related Papers
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
|Seminars in Cancer Biology|2017|366
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
|The Lancet Infectious Diseases|2021|119